Showing results (291-300 of 322) with videos related to
Sort By:
Pageof 33
Scandinavian Journal of Gastroenterology|November 1, 1986
Treatment of duodenal ulcer with low-dose antacidsG Lux, H Hentschel, H G Rohner, et al.American Journal of Surgery|January 1, 1992
Role of octreotide in the prevention of postoperative complications following pancreatic resectionM Büchler, H Friess, I Klempa, et al.Endoscopy|November 11, 2005
The Munich Polypectomy Study (MUPS): prospective analysis of complications and risk factors in 4000 colonic snare polypectomiesW Heldwein, M Dollhopf, T Rösch, et al.Scandinavian Journal of Gastroenterology|January 1, 1977
Inhibition by somatostatin of secretin-stimulated pancreatic secretion in man: a study with pure pancreatic juiceS Domschke, W Domschke, W Rösch, et al.Gastroenterology|September 1, 1977
Vasoactive intestinal peptide: a secretin-like partial agonist for pancreatic secretion in manS Domschke, W Domschke, W Rösch, et al.Gut|August 13, 2002
Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trialJ Labenz, A L Blum, W W Bolten, et al.Scandinavian Journal of Gastroenterology. Supplement|January 1, 1976
Relationship of plasma motilin response to lower esophageal sphincter pressure in manW Domschke, G Lux, P Mitznegg, et al.Zeitschrift Fur Gastroenterologie|September 1, 1991
Low-dose antacid therapy in the treatment of duodenal ulcer--a multicentre double-blind trial vs. misoprostolW F Caspary, K J Hengels, H Kunert, et al.Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|August 1, 1994
[Is acrolentiginous melanoma (ALM) more malignant than superficially spreading melanoma (SSM) at a high-risk site? A matched-pair comparison between 113 ALM and SSM within the scope of a multicenter study]H Breuninger, C Köhler, H Drepper, et al.Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|September 1, 1994
[Prognostic advantage for defined risk groups by lymphocyte dissection. Long-term study of 3,616 melanoma patients]H Drepper, C O Köhler, B Bastian, et al.Pageof 33